Detalles de la búsqueda
1.
Psychoneuroimmunology in multiple myeloma and autologous hematopoietic stem cell transplant: Opportunities for research among patients and caregivers.
Brain Behav Immun;
119: 507-519, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38643954
2.
Associations of frailty with symptoms, and HRQOL in older cancer survivors after cancer treatments: a systematic review and meta-analyses.
Qual Life Res;
33(3): 583-598, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37897643
3.
A real-world data analysis of predictors of early mortality after a diagnosis of multiple myeloma.
Cancer;
129(13): 2023-2034, 2023 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36989073
4.
Risk Factors for Immune Checkpoint Inhibitor Immunotherapy Toxicity Among Older Adults with Cancer.
Oncologist;
28(8): e625-e632, 2023 08 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37085156
5.
Peripheral blood CD3+ T-cell gene expression biomarkers correlate with clinical frailty in patients with haematological malignancies.
Br J Haematol;
199(1): 100-105, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35766906
6.
Aging Phenotypes and Restoring Functional Deficits in Older Adults With Hematologic Malignancy.
J Natl Compr Canc Netw;
19(9): 1027-1036, 2021 03 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-33770752
7.
Prevalence of lifestyle behaviors and associations with health-related quality of life among older female cancer survivors.
Support Care Cancer;
29(6): 3049-3059, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33040283
8.
T Cell Transcriptional Profiling and Immunophenotyping Uncover LAG3 as a Potential Significant Target of Immune Modulation in Multiple Myeloma.
Biol Blood Marrow Transplant;
26(1): 7-15, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31445183
9.
Implementing a multidisciplinary approach for older adults with Cancer: geriatric oncology in practice.
BMC Geriatr;
20(1): 231, 2020 07 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32631254
10.
Determining the relationship of p16INK4a and additional molecular markers of aging with clinical frailty in hematologic malignancy.
J Cancer Surviv;
2024 Apr 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38678524
11.
Cellular therapies in older adults with hematological malignancies: A case-based, state-of-the-art review.
J Geriatr Oncol;
15(3): 101734, 2024 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38430810
12.
Understanding the health effects of caregiving stress: New directions in molecular aging.
Ageing Res Rev;
92: 102096, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37898293
13.
The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic review.
Blood Cancer J;
13(1): 6, 2023 01 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36599867
14.
Impact of interval progression before autologous stem cell transplant in patients with multiple myeloma.
Front Oncol;
13: 1216461, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37554170
15.
The Transplantation Ecosystem: A New Concept to Improve Access and Outcomes for Older Allogeneic Hematopoietic Cell Transplantation Patients.
Transplant Cell Ther;
29(10): 632.e1-632.e10, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37137442
16.
Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Systemic Cancer Therapy: ASCO Guideline Update.
J Clin Oncol;
41(26): 4293-4312, 2023 09 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37459573
17.
Multidisciplinary Approach to Older Adults with Hematologic Malignancies-a Paradigm Shift.
Curr Hematol Malig Rep;
17(1): 31-38, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35028826
18.
Clinical Presentation, Risk Factors, and Outcomes of Immune Effector Cell-Associated Neurotoxicity Syndrome Following Chimeric Antigen Receptor T Cell Therapy: A Systematic Review.
Transplant Cell Ther;
28(6): 294-302, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35288347
19.
Infrastructure to Support Accrual of Older Adults to National Cancer Institute Clinical Trials.
J Natl Cancer Inst Monogr;
2022(60): 151-158, 2022 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36519814
20.
Incidence, Treatment, and Survival of Patients With T-Cell Lymphoma, T-Cell Large Granular Leukemia, and Concomitant Plasma Cell Dyscrasias.
Front Oncol;
12: 858426, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35574379